There were 2,239 press releases posted in the last 24 hours and 359,205 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Aligos Therapeutics on Track to Complete Phase 2-Enabling Activities in 2023 for its Clinically Validated THR-ß Drug Candidate for NASH, ALG-055009

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image